Table of Content

1 Meningococcal Infections Vaccine Market Introduction and Overview
1.1 Meningococcal Infections Vaccine Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Meningococcal Infections Vaccine Revenue and Market Share by Manufacturer
2.2 Manufacturers Meningococcal Infections Vaccine Production Sites, Area Served, Product Types
2.3 Meningococcal Infections Vaccine Market Competitive Situation and Trends
2.3.1 Meningococcal Infections Vaccine Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2024
2.3.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 Sanofi-Pasteur
3.1.1 Sanofi-Pasteur Company Profile
3.1.2 Meningococcal Infections Vaccine Product Overview
3.1.3 Sanofi-Pasteur Meningococcal Infections Vaccine Market Performance (2019-2024)
3.1.4 Sanofi-Pasteur Business Overview
3.2 Beijing Tiantan Biological Products
3.2.1 Beijing Tiantan Biological Products Company Profile
3.2.2 Meningococcal Infections Vaccine Product Overview
3.2.3 Beijing Tiantan Biological Products Meningococcal Infections Vaccine Market Performance (2019-2024)
3.2.4 Beijing Tiantan Biological Products Business Overview
3.3 Shanghai Institute of Biological Products
3.3.1 Shanghai Institute of Biological Products Company Profile
3.3.2 Meningococcal Infections Vaccine Product Overview
3.3.3 Shanghai Institute of Biological Products Meningococcal Infections Vaccine Market Performance (2019-2024)
3.3.4 Shanghai Institute of Biological Products Business Overview
3.4 Wuhan Institute of Biological Products
3.4.1 Wuhan Institute of Biological Products Company Profile
3.4.2 Meningococcal Infections Vaccine Product Overview
3.4.3 Wuhan Institute of Biological Products Meningococcal Infections Vaccine Market Performance (2019-2024)
3.4.4 Wuhan Institute of Biological Products Business Overview
3.5 Lanzhou Institute of Biological Products
3.5.1 Lanzhou Institute of Biological Products Company Profile
3.5.2 Meningococcal Infections Vaccine Product Overview
3.5.3 Lanzhou Institute of Biological Products Meningococcal Infections Vaccine Market Performance (2019-2024)
3.5.4 Lanzhou Institute of Biological Products Business Overview
3.6 Hualan Biological Engineering
3.6.1 Hualan Biological Engineering Company Profile
3.6.2 Meningococcal Infections Vaccine Product Overview
3.6.3 Hualan Biological Engineering Meningococcal Infections Vaccine Market Performance (2019-2024)
3.6.4 Hualan Biological Engineering Business Overview
3.7 Chongqing Zhifei Biological Products
3.7.1 Chongqing Zhifei Biological Products Company Profile
3.7.2 Meningococcal Infections Vaccine Product Overview
3.7.3 Chongqing Zhifei Biological Products Meningococcal Infections Vaccine Market Performance (2019-2024)
3.7.4 Chongqing Zhifei Biological Products Business Overview
3.8 Zhejiang Tianyuan Bio-Pharmaceutical
3.8.1 Zhejiang Tianyuan Bio-Pharmaceutical Company Profile
3.8.2 Meningococcal Infections Vaccine Product Overview
3.8.3 Zhejiang Tianyuan Bio-Pharmaceutical Meningococcal Infections Vaccine Market Performance (2019-2024)
3.8.4 Zhejiang Tianyuan Bio-Pharmaceutical Business Overview
3.9 Walvax Biotechnology
3.9.1 Walvax Biotechnology Company Profile
3.9.2 Meningococcal Infections Vaccine Product Overview
3.9.3 Walvax Biotechnology Meningococcal Infections Vaccine Market Performance (2019-2024)
3.9.4 Walvax Biotechnology Business Overview
4 Global Meningococcal Infections Vaccine Historical and Forecast Market Analysis by Type
4.1 Global Meningococcal Infections Vaccine Revenue and Market Share by Type
4.2 Global Meningococcal Infections Vaccine Revenue Market Forecast by Type (2024-2030)
5 Global Meningococcal Infections Vaccine Historical and Forecast Market Analysis by Application
5.1 Global Meningococcal Infections Vaccine Revenue Market Share by Application (2019-2024)
5.2 Meningococcal Infections Vaccine Revenue Market Forecast by Application (2024-2030)
6 Global Market Growth Trends Analysis
6.1 Global Meningococcal Infections Vaccine Market Size & Forecast (2019-2030)
6.2 Meningococcal Infections Vaccine Growth Trends Analysis by Regions
6.2.1 Meningococcal Infections Vaccine Market Size by Regions: 2019 VS 2024 VS 2030
6.2.2 Meningococcal Infections Vaccine Historic Revenue Market Size by Regions (2019-2024)
6.2.3 Meningococcal Infections Vaccine Forecasted Revenue Market Size by Regions (2024-2030)
6.2.4 North America Meningococcal Infections Vaccine Market Size & Forecast (2019-2030)
6.2.5 Europe Meningococcal Infections Vaccine Market Size & Forecast (2019-2030)
6.2.6 China Meningococcal Infections Vaccine Market Size & Forecast (2019-2030)
6.2.7 Japan Meningococcal Infections Vaccine Market Size & Forecast (2019-2030)
6.2.8 Korea Meningococcal Infections Vaccine Market Size & Forecast (2019-2030)
6.2.9 Southeast Asia Meningococcal Infections Vaccine Market Size & Forecast (2019-2030)
6.2.10 India Meningococcal Infections Vaccine Market Size & Forecast (2019-2030)
6.2.11 South America Meningococcal Infections Vaccine Market Size & Forecast (2019-2030)
6.2.12 Middle East & Africa Meningococcal Infections Vaccine Market Size & Forecast (2019-2030)
7 North America
7.1 North America Meningococcal Infections Vaccine Revenue by Players
7.2 North America Meningococcal Infections Vaccine Revenue by Types
7.3 North America Meningococcal Infections Vaccine Revenue by Applications
7.4 North America Meningococcal Infections Vaccine Revenue, Gross and Gross Margin (2019-2024)
7.5 North America PEST Analysis
8 Europe
8.1 Europe Meningococcal Infections Vaccine Revenue by Players
8.2 Europe Meningococcal Infections Vaccine Revenue by Types
8.3 Europe Meningococcal Infections Vaccine Revenue by Applications
8.4 Europe Meningococcal Infections Vaccine Revenue, Gross and Gross Margin (2019-2024)
8.5 Europe PEST Analysis
9 China
9.1 China Meningococcal Infections Vaccine Revenue by Players
9.2 China Meningococcal Infections Vaccine Revenue by Types
9.3 China Meningococcal Infections Vaccine Revenue by Applications
9.4 China Meningococcal Infections Vaccine Revenue, Gross and Gross Margin (2019-2024)
9.5 China PEST Analysis
10 Japan
10.1 Japan Meningococcal Infections Vaccine Revenue by Players
10.2 Japan Meningococcal Infections Vaccine Revenue by Types
10.3 Japan Meningococcal Infections Vaccine Revenue by Applications
10.4 Japan Meningococcal Infections Vaccine Revenue, Gross and Gross Margin (2019-2024)
10.5 Japan PEST Analysis
11 Korea
11.1 Korea Meningococcal Infections Vaccine Revenue by Players
11.2 Korea Meningococcal Infections Vaccine Revenue by Types
11.3 Korea Meningococcal Infections Vaccine Revenue by Applications
11.4 Korea Meningococcal Infections Vaccine Revenue, Gross and Gross Margin (2019-2024)
11.5 Korea PEST Analysis
12 Southeast Asia
12.1 Southeast Asia Meningococcal Infections Vaccine Revenue by Players
12.2 Southeast Asia Meningococcal Infections Vaccine Revenue by Types
12.3 Southeast Asia Meningococcal Infections Vaccine Revenue by Applications
12.4 Southeast Asia Meningococcal Infections Vaccine Revenue, Gross and Gross Margin (2019-2024)
12.5 Southeast Asia PEST Analysis
13 India
13.1 India Meningococcal Infections Vaccine Revenue by Players
13.2 India Meningococcal Infections Vaccine Revenue by Types
13.3 India Meningococcal Infections Vaccine Revenue by Applications
13.4 India Meningococcal Infections Vaccine Revenue, Gross and Gross Margin (2019-2024)
13.5 India PEST Analysis
14 South America
14.1 South America Meningococcal Infections Vaccine Revenue by Players
14.2 South America Meningococcal Infections Vaccine Revenue by Types
14.3 South America Meningococcal Infections Vaccine Revenue by Applications
14.4 South America Meningococcal Infections Vaccine Revenue, Gross and Gross Margin (2019-2024)
14.5 South America PEST Analysis
15 Middle East & Africa
15.1 Middle East & Africa Meningococcal Infections Vaccine Revenue by Players
15.2 Middle East & Africa Meningococcal Infections Vaccine Revenue by Types
15.3 Middle East & Africa Meningococcal Infections Vaccine Revenue by Applications
15.4 Middle East & Africa Meningococcal Infections Vaccine Revenue, Gross and Gross Margin (2019-2024)
15.5 Middle East & Africa PEST Analysis
16 Meningococcal Infections Vaccine Business Cost Analysis
16.1 Proportion of Business Cost Structure
16.1.1 Labor Cost
16.1.2 Operating Expenses
16.2 Meningococcal Infections Vaccine Industrial Chain Analysis
17 Meningococcal Infections Vaccine Industry Dynamic Analysis
17.1 Meningococcal Infections Vaccine Market Trends Analysis
17.2 Meningococcal Infections Vaccine Market Drivers Analysis
17.3 Meningococcal Infections Vaccine Market Challenges Analysis
17.4 Meningococcal Infections Vaccine Market Restraints Analysis
18 Research Findings and Conclusion